Back to results
US 8,298,777 B2Granted
Method of identifying transmembrane protein-interacting compounds
AssigneeOmeros Corporation
InventorsBrian F. O'Dowd, Susan R. George
Life of this patent
Estimating the term…
Abstract
A method for screening compounds for their ability to interact with transmembrane proteins is provided. Also provided is a method for determining whether proteins such as transmembrane proteins are able to oligomerise. The method uses a transmembrane protein that comprises a nuclear localization sequence (NLS).
Claims19
A method for screening a candidate compound for its ability to interact with at least one transmembrane protein comprising:
- contacting a eukaryotic cell with a candidate compound, wherein the eukaryotic cell comprises at least one nucleotide sequence encoding a protein comprising a transmembrane protein containing at least one nuclear localisation sequence (NLS) and a detectable moiety and the encoded protein is expressed in the cell;
- and
- determining the distribution of the expressed protein in the eukaryotic cell by detecting the distribution of the detectable moiety in the cell;
- wherein detection of an altered distribution of the detectable moiety in the cell relative to the distribution of the detectable moiety in a control cell not contacted with the candidate compound indicates that the compound interacts with the transmembrane protein, wherein the wild-type transmembrane protein lacks an NLS and the nucleotide sequence encoding the transmembrane protein is modified to encode an NLS.
1 more element
Dependencies are inferred from the claim text.